Skip to content

AOCI at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
-$1.37B+3.8%
Eli Lilly logo
Eli LillyLLY
-$2.83B+24.9%
Pfizer logo
PfizerPFE
-$7.2B+16.1%
Amgen logo
AmgenAMGN
-$190M+17.7%
Revolution Medicines, Inc. logo
Revolution Medicines, Inc.RVMD
-$622K-136%
Tango Therapeutics logo
Tango TherapeuticsTNGX
-$115K-159%

Other financials

Income statement

See full
Operating income-$187.9M-427%
Net income-$183.4M-492%
EPS (diluted)-$0.60-445%

Balance sheet

See full
Cash & equivalents$47.3M-33.0%
Total debt$46.0M-9.6%
Total equity$393.5M-1.5%
Total assets$461.2M-2.1%

Cash flow

See full
Operating cash flow-$27.4M+13.2%
CapEx$36.0K-56.6%
Free cash flow-$27.4M+13.3%

Valuation

See full
Market cap$4.69B+1,196%

Returns & leverage

See full
Return on equity-69.9%+77.1pp
Debt / equity0.1×0.0×
Current ratio9.5×-2.8×

Where this comes from

Reported directly by Erasca, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax.

The official record: Erasca, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Erasca, Inc.'s aoci.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Erasca, Inc.'s AOCI?
Erasca, Inc. (ERAS) reported AOCI of -$699K in Q1 2026.
How has Erasca, Inc.'s AOCI changed year-over-year?
Erasca, Inc.'s AOCI decreased by 211.3% year-over-year, from $628K to -$699K.
What is the long-term trend for Erasca, Inc.'s AOCI?
Over 5 years (2020 to 2025), Erasca, Inc.'s AOCI has grown at a 215.8% compound annual growth rate (CAGR), from $2K to $628K.
What does AOCI mean?
Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.